IP Library Granted Patent US 10,760,043
Granted Patent B2
US 10,760,043 · App. 16/823,269 · Granted Sep 1, 2020

Instruments, modules, and methods for improved detection of edited sequences in live cells

Inventors: Andrew Garst (Boulder, CO); Richard Fox (Boulder, CO); Phillip Belgrader (Pleasanton, CA); Don Masquelier (Boulder, CO)
Assignee: Inscripta, Inc.
C12M47/04C12M23/44C12M29/04C12M33/00C12M47/02C12N15/87B01D63/08B01D69/06B01D71/02B01D2201/0407
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,760,043
App. No.
16/823,269
Granted
Sep 1, 2020
Kind
B2
Abstract

The present disclosure provides instruments, modules and methods for improved detection of edited cells following nucleic acid-guided nuclease genome editing. The disclosure provides improved automated instruments that perform methods—including high throughput methods—for screening cells that have been subjected to editing and identifying cells that have been properly edited.

Claims (39)

1. A method for enriching edited cells during nucleic acid-guided CRISPR nuclease editing comprising:

transforming cells with one or more vectors comprising a promoter driving expression of a CRISPR nuclease, an inducible promoter driving transcription of a guide nucleic acid covalently-linked to a DNA donor;

diluting the transformed cells to a cell concentration to substantially singulate the transformed cells on a first substrate;

growing the substantially singulated cells to form cell colonies on the first substrate under conditions that allow genome repair;

making a replica of the first substrate on a second substrate;

making a replica of the first substrate forming a third substrate;

growing and inducing the replicated cells on the second substrate under conditions that allow genome repair;

growing and inducing the replicated cells on the third substrate under conditions that do not allow genome repair;

comparing cell growth of the replicated cells on the second and third substrates; and

selecting cells from the cell colonies from the first substrate that grow on the second substrate but do not grow on the third substrate.

2. The method of claim 1 , wherein the promoter driving transcription of the guide nucleic acid and donor DNA is a pL promoter.

3. The method of claim 1 , wherein the promoter driving expression of the CRISPR nuclease is an inducible promoter.

4. The method of claim 3 , wherein the inducible promoter driving expression of each of the guide nucleic acid and the CRISPR nuclease is the same inducible promoter.

5. The method of claim 4 , wherein the inducible promoter driving expression of the guide nucleic acid and driving transcription of the guide nucleic acid is a pL promoter.

6. The method of claim 1 , wherein the DNA donor sequence further comprises a PAM-altering sequence.

7. The method of claim 1 , further comprising adding selective agents to medium of the first substrate to select for the one or more vectors.

8. The method of claim 1 , wherein the cells grown on the first, second and third substrates are yeast cells.

9. The method of claim 1 , wherein the cells grown on the first, second and third substrates are bacteria cells and the engine vector further comprises a recombineering system.

10. The method of claim 1 , wherein the cells grown on the first, second and third substrates are mammalian cells.

11. A method for enriching edited cells during nucleic acid-guided CRISPR nuclease editing comprising:

transforming cells with one or more vectors comprising a promoter driving expression of a CRISPR nuclease, an inducible promoter driving transcription of a guide nucleic acid covalently-linked to a DNA donor;

diluting the transformed cells to a cell concentration to substantially singulate the transformed cells on a first substrate;

growing the substantially singulated cells to form colonies on the first substrate under conditions that allow genome repair;

making a replica of the first substrate on a second substrate;

making a replica of the first substrate on a third substrate;

growing the replicated cells on the second substrate for two or more doublings;

inducing the replicated cells on the second substrate under conditions that allow genome repair;

growing the replicated cells on the third substrate for two or more doublings;

inducing the replicated cells on the third substrate under conditions that do not allow genome repair; and

selecting cells from the colonies on the first substrate that grew on the second substrate but do not grow on the third substrate.

12. The method of claim 11 , wherein the promoter driving transcription of the guide nucleic acid and donor DNA is a pL promoter.

13. The method of claim 11 , wherein the promoter driving expression of the CRISPR nuclease is an inducible promoter.

14. The method of claim 13 , wherein the inducible promoter driving expression of each of the guide nucleic acid and the CRISPR nuclease is the same inducible promoter.

15. The method of claim 14 , wherein the inducible promoter driving expression of the guide nucleic acid and driving transcription of the guide nucleic acid is a pL promoter.

16. The method of claim 11 , wherein the DNA donor sequence further comprises a PAM-altering sequence.

17. The method of claim 11 , further comprising adding selective agents to medium of the first substrate to select for the one or more vectors.

18. The method of claim 11 , wherein the cells grown on the first, second and third substrates are yeast cells.

19. The method of claim 11 , wherein the cells grown on the first, second and third substrates are bacteria cells and the engine vector further comprises a recombineering system.

20. The method of claim 11 , wherein the cells grown on the first, second and third substrates are mammalian cells.

Assignments (2)
REAFFIRMATION AGREEMENT Recorded Aug 28, 2022
From: ACRONIS AG; ACRONIS INTERNATIONAL GMBH; ACRONIS SCS, INC.; ACRONIS, INC.; GROUPLOGIC, INC.; NSCALED INC.; ACRONIS MANAGEMENT LLC; 5NINE SOFTWARE, INC.; ACRONIS GERMANY GMBH; ACRONIS NETHERLANDS B.V.; ACRONIS BULGARIA EOOD; DEVICELOCK, INC.; DEVLOCKCORP LTD; ACRONIS INC.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061330/0818 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2020
From: GARST, ANDREW; FOX, RICHARD; BELGRADER, PHILLIP; MASQUELIER, DON
To: INSCRIPTA, INC.
Reel/Frame 052158/0507 →
Continuity (8)
Continuation 16597826 · Oct 9, 2019
Continuation 16454865 · Jun 27, 2019
Continuation 16399988 · Apr 30, 2019
Provisional Application 62781112 · Dec 18, 2018
Provisional Application 62779119 · Dec 13, 2018
Provisional Application 62735365 · Sep 24, 2018
Provisional Application 62718449 · Aug 14, 2018
Related Publication 20200216795A1 · Jul 9, 2020